|
HS Code |
468019 |
| Chemical Formula | C9H15NO2 |
| Molar Mass | 169.22 g/mol |
| Appearance | Typically a colorless to pale yellow liquid or solid |
| Melting Point | Data may vary, but usually in a certain temperature range |
| Solubility | Soluble in common organic solvents like dichloromethane, chloroform |
| Density | Estimated based on related structures |
| Flash Point | Depends on purity and environment, approximate value can be calculated |
| Stability | Stable under normal conditions, but may react with strong acids or bases |
| Reactivity | Can undergo reactions typical of pyrrole derivatives, such as electrophilic substitution |
As an accredited N-Boc-2,5-Dihydro-1H-Pyrrole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of N - Boc - 2,5 - Dihydro - 1H - Pyrrole packaged in a sealed, labeled bottle. |
| Shipping | N - Boc - 2,5 - Dihydro - 1H - Pyrrole is shipped in well - sealed containers, ensuring protection from moisture and air. Shipment follows strict chemical safety regulations, with appropriate hazard labels, via reliable carriers for secure delivery. |
| Storage | N - Boc - 2,5 - Dihydro - 1H - Pyrrole should be stored in a cool, dry place, away from heat and direct sunlight. Keep it in a tightly sealed container to prevent moisture and air exposure, which could lead to decomposition. Store it in a well - ventilated area, preferably in a dedicated chemical storage cabinet to ensure safety and prevent cross - contamination with other substances. |
Maintaining Anhydrous Conditions During Lithiation-Acylation Sequences for CNS APIsWhen synthesising 3-substituted pyrrolidine scaffolds intended for dopaminergic and serotonergic receptor modulation, the anhydrous lithiation of N-Boc-2,5-dihydro-1H-pyrrole constitutes the pivotal C–C bond-forming transformation. Production campaigns executed under ICH Q7 cGMP for active pharmaceutical ingredients require reactor systems capable of excluding atmospheric moisture to a headspace dew point below -80 °C, typically achieved inside 316L stainless-steel jacketed vessels with PTFE-encapsulated seals and retreat-curve impellers providing 1.2–2.0 kW·m−3 specific power input. The enamine-type anion is generated by controlled addition of 1.0–1.05 molar equivalents of lithium diisopropylamide in tetrahydrofuran/n-hexane at a jacket-set temperature of -75 ± 3 °C, with an internal process temperature maintained below -65 °C throughout the 45–60 minute addition window. Exotherms exceeding -60 °C trigger a kinetic competition between deprotonation at the α-position of nitrogen and proton scrambling to the thermodynamically more stable β-enamine anion, which diverts the anion pool into a regioisomeric species that reduces the yield of the target 2-alkylated dihydropyrrole by ≥15% and generates a persistent by-product difficult to separate by rectification. The resultant dark-violet lithio-dihydropyrrole solution is subsequently treated with an electrophile—methyl iodide, allyl bromide, or ethyl chloroformate—at 1.10–1.20 equivalents, with the alkylating agent pre-cooled to -50 °C to avoid local thermal runaway. Reaction progress is tracked by inline ReactIR 15 disappearance of the enamine absorption at ~1630 cm⁻¹, and once conversion exceeds 99.0% the mixture is quenched into chilled 15 wt% ammonium chloride solution using a continuous centrifugal extractor operating at 2000–3000 rpm to suppress emulsification. The isolated organic phase is concentrated in vacuo and purified via a wiped-film evaporator at 0.5–2 mbar jacket temperature 120–140 °C, delivering the N-Boc-2-substituted-2,5-dihydro-1H-pyrrole intermediate with a purity exceeding 98.0% as determined by HPLC area-percent at 210 nm. Subsequent hydrogenation over 5 wt% Pd/C in methanol at 3 bar and 25–35 °C saturates the olefin and, upon acidic work-up and thermal equilibration, drives isomerisation to the desired 3-substituted pyrrolidine framework—a core structural element in dopamine D3 receptor antagonists (development candidates for substance-use disorders), vesicular monoamine transporter 2 (VMAT2) inhibitors indicated for hyperkinetic movement disorders, and 5-HT1A partial agonists. Regulatory filing enforce compliance with ICH Q3C residual solvent thresholds (tetrahydrofuran ≤ 720 ppm, n-hexane ≤ 290 ppm, ethyl acetate ≤ 5000 ppm) and ICH Q3D elemental impurity control (Class 1 metals below 2.5 μg/day, Class 2A cobalt ≤ 5 μg/day). Manufacture of chiral oxazolidinone auxiliaries for asymmetric Evans alkylation frequently proceeds via nucleophilic epoxide opening with the lithium alkoxide derived from N-Boc-2,5-dihydro-1H-pyrrole. In multikilogram campaigns conducted under ISO 9001:2015 quality management and REACH Regulation (EC) No 1907/2006, the dihydropyrrole is first reduced under hydrogen pressure—3–5 bar over Raney nickel grade 2800 in methanol at 50–60 °C—to yield N-Boc-pyrrolidine, which is subsequently lithiated at -10–0 °C with 1.0–1.05 equivalents of n-butyllithium (2.5 M in hexanes) in anhydrous tetrahydrofuran containing 2.5 equivalents of TMEDA to enhance anion generation. To the resulting lithium pyrrolidide is added 1.0 equivalent of (S)-glycidyl nosylate or epichlorohydrin, maintaining an internal temperature below 5 °C for 2–3 h until diastereomeric excess reaches a plateau above 95% as monitored by chiral HPLC on an Chiralpak AD-H column with n-hexane/2-propanol mobile phase. The resultant amino alcohol is cyclised in refluxing toluene containing catalytic p-toluenesulfonic acid monohydrate (0.05 eq.) under Dean–Stark water removal, yielding the oxazolidinone ring in 85–92% yield after fractional distillation. Application as a stoichiometric auxiliary then requires N-acylation with propionyl chloride and stereoselective alkylation employing lithium bis(trimethylsilyl)amide at -78 °C with optimized cryogenic heat transfer. The oxazolidinone auxiliaries ultimately prepared through this route—(4S)-4-benzyl-2-oxazolidinone and its gem-dimethyl analogue—are used industrially to construct β-lactam antibiotic side-chains, statin intermediates, and single-enantiomer non-steroidal anti-inflammatory agents. The pyrrolidine moiety liberated upon auxiliary cleavage is recovered via Boc re-protection and vacuum distillation, satisfying waste-minimisation targets under ISO 14001. Where Does N-Boc-2,5-Dihydro-1H-Pyrrole Fit in the Synthesis of Insecticidal Nicotinic Acetylcholine Receptor Modulators?The pyrrolidine ring embedded in neonicotinoid pharmacophores imposes strict steric and electronic constraints that are accessed through catalytic hydrogenation of N-Boc-2,5-dihydro-1H-pyrrole to N-Boc-pyrrolidine, followed by acidic N-deprotection using anhydrous HCl in dioxane. Pre-registration data packages prepared under 40 CFR Part 158 (United States Federal Insecticide, Fungicide, and Rodenticide Act) and Regulation (EC) No 1107/2009 (EU plant protection products) require a fully documented impurity profile for the active substance manufacturing stream; residual Boc-related by-products—chiefly tert-butanol and di-tert-butyl dicarbonate—must be maintained below 0.15% w/w in the technical-grade concentrate. In the crucial coupling step, the free pyrrolidine intermediate is reacted with a chloromethyl-substituted heterocycle—most commonly a 2-chloro-5-chloromethylthiazole or 2-chloro-5-chloromethylpyridine core—at 1.0–1.3 molar equivalents relative to the heterocycle in acetonitrile containing 1.5 equivalents of milled potassium carbonate as acid scavenger. The nucleophilic substitution is conducted in glass-lined batch reactors at 55–65 °C, with agitation rates of 150–180 rpm to maintain suspension of the inorganic base, and reaction progress assessed via in-process HPLC until the chloromethyl precursor drops below 0.5% area (8–12 h typical). Crude agrochemical active is isolated by quenching into water, extracting into ethyl acetate, and purifying via recrystallisation from isopropanol/deionised water (4:1 v/v), yielding a crystalline solid with a melting point range narrower than 2 °C. The final products—3-(pyrrolidin-1-ylmethyl)-substituted neonicotinoid analogues—exhibit modulated lipophilicity (log P reduced by 0.4–0.8 units relative to pyridylmethyl counterparts) designed to lower intrinsic honeybee toxicity while preserving high-affinity binding to insect nicotinic acetylcholine receptors (IC50 values < 50 nM against Myzus persicae receptor preparations). Adherence to FAO Specification 50/TC ensures the quality of technical concentrate lots, and REACH tonnage-band registration triggers extended one-generation reproductive toxicity evaluations (OECD Test No. 443) for quantities exceeding 10 tonnes per annum, along with aquatic ecotoxicity testing under OECD 201/202/203 guidelines. Spin-coated films of chemically amplified photoresists formulated with a methacrylate monomer incorporating N-Boc-2,5-dihydro-1H-pyrrole as an acid-labile pendant group rely on the thermally activated, photoacid-catalysed cleavage of the carbamate linkage to generate gaseous isobutylene and carbon dioxide while unmasking a secondary amine that dramatically increases the dissolution rate in aqueous alkaline developer. A typical terpolymer is synthesised in propylene glycol methyl ether acetate (PGMEA) via conventional free-radical polymerisation using 2’,2’-azobis(isobutyronitrile) initiator at 70 °C; the feed incorporates 8–15 mole percent of the pyrroline-containing monomer, balanced against methyl methacrylate and t-butyl methacrylate to tune the base resin glass transition temperature to 145–170 °C and optimise the dissolution rate contrast. Coating onto 200 mm silicon wafers primed with hexamethyldisilazane using an automated track dispense system produces films with a post-apply thickness of 300–500 nm after a soft-bake on a proximity hotplate at 120 °C for 90 seconds. Following slit-scan exposure at 248 nm (KrF excimer laser, typical dose 25–40 mJ·cm−2) and a post-exposure bake at 105–115 °C for 60 seconds, development in 0.26 N tetramethylammonium hydroxide with 30–60 second puddle dispense reveals positive-tone contact-hole and line/space patterns with dark-film thickness loss below 2 nm. The entire lithographic process frame is subject to SEMI S2 environmental, health, and safety compliance for wafer fabrication equipment and SEMI S8 ergonomics guidelines, while the final electronic-component polymer must satisfy the restrictions on hazardous substances enumerated in RoHS Directive 2011/65/EU (Annex II). The resulting resist matrices enable pattern transfer at 0.25–0.18 µm design rules, serving as buried-layer and gate-level masking essential for DRAM stacked-capacitor architectures and logic-node front-end-of-line manufacturing. Published data on this specific monomer configuration indicates that the latent image stability between exposure and post-exposure bake becomes the limiting process parameter at relative humidity exceeding 55%. |
Competitive N-Boc-2,5-Dihydro-1H-Pyrrole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Grade | Purity (GC-FID, %area) | Water Content (KF, ppm) | Free Amine (HPLC-UV, %area) | Isolated Yield (%) | Purity of Crude Product (%) |
|---|---|---|---|---|---|
| Technical (non-distilled) | 95.8 | 820 | 1.4 | 41 | 88.2 |
| Distilled, single fraction | 97.9 | 190 | 0.6 | 58 | 93.5 |
| Distilled, centre cut, argon purged | 99.2 | 65 | 0.08 | 79 | 97.1 |
| Distilled, centre cut, alumina-filtered | 99.6 | 42 | 0.03 | 84 | 98.4 |
| Parameter | N-Boc-2,5-dihydro-1H-pyrrole (BPD‑100‑01) | N-Boc-pyrrolidine (BPD‑200‑01) | Method |
|---|---|---|---|
| Assay (anhydrous, solvent-free) | ≥98.5% | ≥99.0% | GC-FID (ASTM E594-96) |
| Water content | ≤0.1% | ≤0.05% | Karl Fischer (ISO 760:1978) |
| Free amine (2,5-dihydropyrrole) | ≤0.2% | Not applicable | HPLC-UV 210 nm |
| N-Boc-pyrrolidine content | ≤0.5% | Not applicable | GC-MS, SIM mode |
| Boiling point | 208–210 °C (dec), 70–72 °C at 0.4 mbar | 238–240 °C, 105–107 °C at 13 mbar | Dynamic vacuum distillation |
| Storage condition | −25 °C to −15 °C, argon | 2–8 °C, sealed | ICH Q1A(R2) |
| ROMP monomer activity (G2, CD2Cl2, RT) | Initiation complete within ≤30 min | No polymerisation observed | 1H NMR kinetics |